购物车
- 全部删除
- 您的购物车当前为空
BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes.
BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | BR102375 is a non-TZD PPAR γ full agonist (EC50: 0.28 μM) for the treatment of type 2 diabetes. |
体外活性 | BR102375 (Compound 18) (10 μM) increases gene expression levels relevant to PPARγ activation and enhances glucose uptake under insulin stimulation. BR102375 (10 nM, 100 nM, 1 μM; 6 days, 14 days) shows a concentration-dependent, insulin-sensitive effects on adipogenesis [1]. |
体内活性 | BR102375 has decent efficacy on the mouse diabetes model.BR102375 reveals significant suppressive effect on random blood glucose increase(75 mpk, p.o., bid), shows a decent effect on insulin resistance on the Oral glucose tolerance test (OGTT), and discloses similar findings in body weight gain almost identical to Pioglitazone [1]. |
分子量 | 554.64 |
分子式 | C31H34N6O4 |
CAS No. | 2366255-59-4 |
密度 | 1.28 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容